Quartz
Subscribe
Quartz
Subscribe
Edition
Business News
A.I.
Technology
Money & Markets
Leadership
Lifestyle
Latest

Get Quartz in your inbox

Free daily briefing on global business news.

Business News
AirlinesAutomobilesFoodPharmaceuticalsPolitics & GovernmentRetail & EcommerceSpace & AerospaceEarnings
Technology
A.I.ComputingConsumer TechSpace & AerospaceEarnings
Money & Markets
Economic IndicatorsMarketsPersonal FinanceEarnings
Lifestyle
Cars & BikesCollectingEntertainmentFood & Fine DiningHealth and FitnessReal EstateTravel
Quartz

Global business news for a smarter world

Topics

  • Business News
  • Money & Markets
  • Tech & Innovation
  • Generation A.I.
  • Lifestyle
  • Leadership

Products

  • Daily Brief
  • Weekly Digest
  • Member Benefits
  • Quartz Pro

Legal

  • Sitemap
  • About
  • Accessibility
  • Privacy
  • Terms of Service
  • Advertising

© 2026 Quartz Media, Inc. All rights reserved.

Airlines

Southwest Airlines is threatening a hedge fund with a 'poison pill'

The measure would dilute activist investor Elliott Management's 11% stake if the company acquires too many more shares

By Melvin Backman·1 min read·Updated August 6, 2024
Add QZ to Google

The battle to control Southwest Airlines just got a little trickier. The company announced Wednesday that it’s adopting a so-called “poison pill” defense in its bid to fend off hedge fund Elliott Management. The provision, outlined as part of a newly unveiled “shareholder rights plan,” would expand the number of Southwest shares outstanding and dilute Elliott’s sizeable stake if the fund tries to acquire a bigger percentage of the company.

“In light of the potential for Elliott to significantly increase its position in Southwest Airlines, the Board determined that adopting the Rights Plan is prudent to fulfill its fiduciary duties to all Shareholders,” Southwest board chairman Gary Kelly said in a statement, adding that the board is “confident that we have the right strategy, the right plan, and the right team in place to succeed.”

Elliott announced last month that it had acquired an 11% stake in Southwest with plans to turn around the carrier’s recent downward trajectory with a “comprehensive business review.” The company’s new poison pill awards every shareholder except Elliott the chance to double their holdings for half price if Elliott acquires 12.5% or more of the company.

Southwest shares were flat in early Wednesday trading and are down 1% for the year.

Daily Brief

The essential business news, delivered fresh every morning.

Join 500,000+ readers who start their day with Quartz.

By subscribing, you agree to our Terms of Service and Privacy Policy.

Related

PharmaBristol Myers Squibb is deploying NVIDIA's most powerful AI computing system to speed drug discovery
Money & MarketsOil spikes as Trump says Iran will pay "many times over" for killing three US soldiers
RetailE.U. hits AliExpress with a record €550 million fine for allowing illegal product sales
MarketsJersey Mike's is kicking off its IPO roadshow, targeting up to $1.09 billion
A.I.Head of U.S. federal AI testing institute resigned after just three months